Clinical Trials

Showing trials with last updates posted in 2024.

NCT03971474 | COMPLETED | PHASE2
166 participants

Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2024-09-03
Start Date:
2019-05-28
Completion:
2022-04-14
Conditions
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • DRUG
  • BIOLOGICAL
NCT03530683 | TERMINATED | PHASE1
189 participants

A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma

Study Type:
INTERVENTIONAL
Last Updated:
2024-09-03
Start Date:
2018-05-14
Completion:
2024-07-18
Conditions
  • Lymphoma
  • Multiple Myeloma
  • Acute Myeloid Leukemia
  • Diffuse Large B-Cell Lymphoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page